Crossject Société Anonyme (EPA:ALCJ)
France · Delayed Price · Currency is EUR 2.045
-0.035 (-1.68%)
Apr 2, 2026, 5:35 PM CET
Crossject Société Anonyme Market Cap
Crossject Société Anonyme has a market cap or net worth of €107.85 million as of April 2, 2026. Its market cap has increased by 29.04% in one year.
Market Cap
107.85M
Enterprise Value
125.22M
Revenue
2.57M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.05
Market Cap Chart
Since February 20, 2014, Crossject Société Anonyme's market cap has increased from 59.40M to 107.85M, an increase of 81.57%. That is a compound annual growth rate of 5.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 107.85M | -6.62% |
| Dec 31, 2025 | 115.50M | 10.53% |
| Dec 31, 2024 | 104.50M | -44.71% |
| Dec 29, 2023 | 188.99M | 90.83% |
| Dec 30, 2022 | 99.04M | 26.25% |
| Dec 31, 2021 | 78.44M | 0.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 99.72B |
| EssilorLuxottica Société anonyme | 88.27B |
| Sartorius Stedim Biotech | 16.45B |
| Ipsen | 13.75B |
| ABIONYX Pharma | 130.35M |
| Euroapi | 120.45M |
| Guerbet | 114.55M |
| Innate Pharma | 108.91M |